Induction chemotherapy followed by concurrent chemoradiotherapy is benefit for advanced stage nasopharyngeal carcinoma with different nonkeratinizing carcinoma subtypes-Reference-Cited by-同舟云学术

Induction chemotherapy followed by concurrent chemoradiotherapy is benefit for advanced stage nasopharyngeal carcinoma with different nonkeratinizing carcinoma subtypes

Published:2018-09-06 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zang Jian,Li Chen,Xu Man,Xu Wanni,Kang Xiaowei,Wang Jianhua,Luo Shanquan,Shi Mei

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-31050-z.pdf

Reference28 articles.

1. Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87–108, https://doi.org/10.3322/caac.21262 (2015).

2. Cheng, S. H. et al. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. International journal of radiation oncology, biology, physics 50, 717–726 (2001).

3. Ou, S. H., Zell, J. A., Ziogas, A. & Anton-Culver, H. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Annals of oncology: official journal of the European Society for Medical Oncology 18, 29–35, https://doi.org/10.1093/annonc/mdl320 (2007).

4. Barnes, L. Pathology and genetics of head and neck tumours. (IARC Press, 2005).

5. Zang, J. et al. Prognostic Model of Death and Distant Metastasis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China. Medicine 95, e3794, https://doi.org/10.1097/MD.0000000000003794 (2016).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors;International Forum of Allergy & Rhinology;2024-01-02

2. Therapeutic Evaluation of Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma With Low-risk N Stage;American Journal of Clinical Oncology;2023-03-07

3. Optimize the number of cycles of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis;Journal of Cancer;2022

4. Efficiency of high cumulative cisplatin dose in high‐ and low‐risk patients with locoregionally advanced nasopharyngeal carcinoma;Cancer Medicine;2021-12-03

5. Residual Volume of Lymph Nodes During Chemoradiotherapy Based Nomogram to Predict Survival of Nasopharyngeal Carcinoma Patient Receiving Induction Chemotherapy;Frontiers in Oncology;2021-09-06